SCHEMBL505409

SCHEMBL505409

O=C1Nc2c(cccc2[N+](=O)[O-])C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 2/20 0.55
DAO P14920 2/20 0.53
CES1 P23141 2/20 0.53
NSD2 O96028 1/20 0.53
BCHE P06276 1/20 0.53
PTPRC P08575 1/20 0.50
LIG1 P18858 1/20 0.49
XDH P47989 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.45
RECQL P46063 1/20 0.45
MCL1 Q07820 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
TDP2 O95551 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5945174 0.78 KMT2A (0.51) S100A4PTPRCXDHCA1CA2
SCHEMBL8616616 0.76 CCNB2 (0.39) S100A4DAOPTPRCLIG1XDH
SCHEMBL7497126 0.74 KMT2A (0.49) S100A4PTPRCXDHCA1CA2
SCHEMBL9016208 0.74 CAPN9 (0.54) S100A4CES1PTPRCKMT2AMEN1
SCHEMBL27198984 0.74 ALDH1A1 (0.46) S100A4PTPRCXDHCA1CA2
SCHEMBL30776836 0.74 ALDH1A1 (0.46) S100A4PTPRCXDHCA1CA2
SCHEMBL4612017 0.73 PARP1 (0.53) S100A4CES1BCHEPTPRCXDH
SCHEMBL30050991 0.73 SMN1; SMN2 (0.61) S100A4PTPRCCA1CA2CA7
SCHEMBL284027 0.73 SMN1; SMN2 (0.61) S100A4PTPRCCA1CA2CA7
SCHEMBL505202 0.72 S100A4 (0.49) S100A4CES1XDHMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845388-A Method for synthesizing 7-nitroindole 江苏苏利精细化工股份有限公司 2020-02-28 CN claimed
EP-1432395-B1 METHOD FOR COLOURING KERATIN FIBRES USING CARBONYL COMPOUNDS TO IMPROVE THE COLOUR STABILITY OF HAIR COLORATION HENKEL AG & CO KGAA (DE) 2012-08-08 EP claimed
EP-2414328-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA (CH) 2021-05-26 EP disclosed
EP-2414328-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA (CH) 2021-05-26 EP disclosed
CN-110845388-A Method for synthesizing 7-nitroindole 江苏苏利精细化工股份有限公司 2020-02-28 CN disclosed
CN-110845388-A Method for synthesizing 7-nitroindole 江苏苏利精细化工股份有限公司 2020-02-28 CN disclosed
CN-110325514-A Trisubstituted -2- alkyl -1H- benzo [d] imdazole derivatives of 1,4,6- as dihydrooratic acid oxygenase inhibitor 默克专利有限责任公司 2019-10-11 CN disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
CN-104030987-A DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA 2014-09-10 CN disclosed
CN-103922948-A Preparation method of 2-amino-3-nitrobenzoic acid QINGDAO XUEJIE CHEMICALS CO LTD 2014-07-16 CN disclosed
EP-2414328-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Merck Serono S.A. (CH) 2012-02-08 EP disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed
WO-2001053251-A1 PROCESS FOR PRODUCING 3-NITRO-2-(MONO-SUBSTITUTED)AMINOBENZOIC ACID ESTER SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2001-07-26 WO disclosed
JP-2001163843-A METHOD FOR PRODUCING 3-NITRO-2-AMINOBENZOIC ACID SUMITOMO SEIKA CHEM CO LTD 2001-06-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD S100A4 4628/4885DAO 271/4885CES1 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.